PTPRD and breast carcinoma: In postmenopausal patients with breast cancer, we found that underweight patients harbored significantly more BRIP1, CDK12, JAK1, MYC, and TP53 mutations, whereas overweight patients harbored more EPHA5 and PTPRD mutations.